Paid Clinical Trials Saint Paul

Discover 1,044 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,044

Beta BlockerCSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Recruiting

PHASE3

Sponsor:

VA Office of Research and Development

Location:

Minneapolis MN, New York NY, Boston MA

Code:

NCT05931276

Conditions

End-Stage Kidney Disease

End-Stage Renal Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Metoprolol Succinate

Carvedilol

Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Saint Paul MN, Maplewood MN, Minneapolis MN, Fridley MNshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Minneapolis MN, Marshfield WI, London, Columbus OHshow 34 more

Code:

NCT05552976

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mezigdomide

Carfilzomib

Dexamethasone

CenerimodA Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

Recruiting

PHASE3

Sponsor:

Idorsia Pharmaceuticals Ltd.

Location:

Eagan MN, Orland Park IL, Duncansville PA, Colleyville TXshow 20 more

Code:

NCT05672576

Conditions

Lupus Erythematosus, Systemic

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Cenerimod

Placebo

LY3541860A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Eagan MN, Willowbrook IL, Duncansville PA, Lake Charles LAshow 16 more

Code:

NCT06859294

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LY3541860

KetamineKetamine-enhanced Prolonged Exposure Therapy in PTSD

Recruiting

PHASE2

Sponsor:

VA Office of Research and Development

Location:

Minneapolis MN

Code:

NCT04560660

Conditions

PTSD

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ketamine

Midazolam

CRT OptimizationEffects of CRT Optimization as Assessed by Cardiac MR

Recruiting

Sponsor:

Allina Health System

Location:

Saint Paul MN, Minneapolis MN

Code:

NCT04763460

Conditions

Heart Failure, Systolic

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Programming of CRT device settings

RavulizumabStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Minneapolis MN, Iowa City IA, Milwaukee WI, Winnipegshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Quemliclustat & ChemotherapyStudy of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Recruiting

PHASE3

Sponsor:

Arcus Biosciences, Inc.

Location:

Minneapolis MN, Rochester MN, Madison WI, Chicago ILshow 29 more

Code:

NCT06608927

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Quemliclustat

Placebo

Nab-paclitaxel

Gemcitabine

HLA TestingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Minneapolis MN, Detroit MI, Louisville KY, Cleveland OHshow 13 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling